JnJ_LogoJohnson & Johnson has accepted the offer of US$ 1.94 billion from Cardinal Health to acquire its Cordis business.Accepted after consultations with relevant works councils and trade unions, the offer was first announced in March this year by Cardinal Health.

The company expects the transaction to close toward the end of 2015, subject to regulatory clearances and other customary closing conditions.

Cordis develops and manufactures interventional vascular technology products, partnering with experts worldwide to treat millions of patients who suffer from vascular disease. The company, which reported annual sales of US$ 780 million in 2014, carries out operations in about 50 countries, including China, Japan, Germany, Italy, France, UK and Brazil.

Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.

Related Corporate Updates